Masami Hirano

2.0k total citations
55 papers, 1.4k citations indexed

About

Masami Hirano is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Masami Hirano has authored 55 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 18 papers in Pathology and Forensic Medicine and 14 papers in Oncology. Recurrent topics in Masami Hirano's work include Lymphoma Diagnosis and Treatment (18 papers), Acute Myeloid Leukemia Research (9 papers) and Chronic Lymphocytic Leukemia Research (7 papers). Masami Hirano is often cited by papers focused on Lymphoma Diagnosis and Treatment (18 papers), Acute Myeloid Leukemia Research (9 papers) and Chronic Lymphocytic Leukemia Research (7 papers). Masami Hirano collaborates with scholars based in Japan, United States and India. Masami Hirano's co-authors include Masataka Okamoto, Nozomi Niitsu, Hirokazu Nakamine, Syu-ichi Hirai, Tsutomu Aoki, Jun‐ichiro Inoue, Shin‐Ichi Osada, Shigeo Ohno, Masahiko Hosaka and Shigenobu Kanba and has published in prestigious journals such as New England Journal of Medicine, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Masami Hirano

53 papers receiving 1.4k citations

Peers

Masami Hirano
Hans Hartung Germany
Thaddeus J. Unger United States
Jack C. Sipe United States
Gilles Edan France
Sara Rollinson United Kingdom
Jacek Losy Poland
S Nakazawa Japan
Bonaventura Casanova Spain
Anne Waschbisch Germany
Carlo Avolio Italy
Hans Hartung Germany
Masami Hirano
Citations per year, relative to Masami Hirano Masami Hirano (= 1×) peers Hans Hartung

Countries citing papers authored by Masami Hirano

Since Specialization
Citations

This map shows the geographic impact of Masami Hirano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masami Hirano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masami Hirano more than expected).

Fields of papers citing papers by Masami Hirano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masami Hirano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masami Hirano. The network helps show where Masami Hirano may publish in the future.

Co-authorship network of co-authors of Masami Hirano

This figure shows the co-authorship network connecting the top 25 collaborators of Masami Hirano. A scholar is included among the top collaborators of Masami Hirano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masami Hirano. Masami Hirano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hirano, Masami, et al.. (2014). Effects of 2 weeks of low-intensity cycle training with different pedaling rates on the work rate at lactate threshold. European Journal of Applied Physiology. 115(5). 1005–1013. 11 indexed citations
2.
3.
Niitsu, Nozomi, Masataka Okamoto, Hirokazu Nakamine, & Masami Hirano. (2010). Clinicopathologic correlations of diffuse large B‐cell lymphoma in rheumatoid arthritis patients treated with methotrexate. Cancer Science. 101(5). 1309–1313. 58 indexed citations
4.
Niitsu, Nozomi, Masataka Okamoto, Ikuo Miura, & Masami Hirano. (2008). Clinical significance of 8q24/c‐MYC translocation in diffuse large B‐cell lymphoma. Cancer Science. 100(2). 233–237. 40 indexed citations
5.
Niitsu, Nozomi, Masataka Okamoto, Hirokazu Nakamine, et al.. (2008). Clinico‐pathologic features and outcome of Japanese patients with peripheral T‐cell lymphomas. Hematological Oncology. 26(3). 152–158. 32 indexed citations
6.
Niitsu, Nozomi, Masataka Okamoto, Naoya Nakamura, et al.. (2007). Prognostic impact of chromosomal alteration of 3q27 on nodal B-cell lymphoma: Correlation with histology, immunophenotype, karyotype, and clinical outcome in 329 consecutive patients. Leukemia Research. 31(9). 1191–1197. 9 indexed citations
7.
Niitsu, Nozomi, Masataka Okamoto, Naoto Tomita, et al.. (2006). Multicentre phase II study of the baseline BEACOPP regimen for patients with advanced-stage Hodgkin's lymphoma. Leukemia & lymphoma. 47(9). 1908–1914. 10 indexed citations
8.
Niitsu, Nozomi, et al.. (2006). Multicenter phase II study of CyclOBEAP regimen for elderly patients with poor‐prognosis aggressive lymphoma. Hematological Oncology. 24(4). 220–226.
9.
Niitsu, Nozomi, Masataka Okamoto, Tadashi Yoshino, et al.. (2006). t(8;14)(q24;q32) in two patients with CD10-negative primary thyroid diffuse large B-cell lymphoma. Leukemia Research. 31(5). 707–711. 1 indexed citations
10.
Shioe, Kunihiko, Tetsuya Ichimiya, Tetsuya Suhara, et al.. (2003). No association between genotype of the promoter region of serotonin transporter gene and serotonin transporter binding in human brain measured by PET. Synapse. 48(4). 184–188. 139 indexed citations
11.
Niitsu, Nozomi, Masataka Okamoto, Hirokazu Nakamine, et al.. (2002). Simultaneous elevation of the serum concentrations of vascular endothelial growth factor and interleukin‐6 as independent predictors of prognosis in aggressive non‐Hodgkin's lymphoma. European Journal Of Haematology. 68(2). 91–100. 70 indexed citations
12.
Hirano, Masami, Shin‐Ichi Osada, Tsutomu Aoki, et al.. (1996). MEK Kinase Is Involved in Tumor Necrosis Factor α-Induced NF-κB Activation and Degradation of IκB-α. Journal of Biological Chemistry. 271(22). 13234–13238. 183 indexed citations
13.
Yamada, Hironori, Nobuhiko Emi, Hidehiko Saito, et al.. (1995). Efficacy of Early Administration of G-CSF After Intensive Chemotherapy in Acute Leukemia: A Randomized Controlled Trial. 36(11). 1257–1265. 3 indexed citations
14.
Kubota, Masaharu, et al.. (1993). Hypothalamic MHPG Measured by Microdialysis in Rats with PNMT Inhibitors. Psychiatry and Clinical Neurosciences. 47(2). 428–428. 2 indexed citations
15.
Asada, Takashi, et al.. (1993). An Autopsy Case of Coexisting Portal Systemic Encephalopathy and Senile Dementia of the Alzheimer Type. Psychiatry and Clinical Neurosciences. 47(3). 651–656. 1 indexed citations
16.
Miyazaki, Hitoshi, Fumio Maruyama, Masataka Okamoto, et al.. (1991). Mixed Lymphocyte-Autologous Tumor Cell Reaction in Hematological Malignancies—Effect of Interferon-β and Correlation with the Expression of MHC Class I Antigen on Tumor Cells. Journal of Interferon Research. 11(5). 305–310. 1 indexed citations
17.
Hirano, Masami, et al.. (1991). A combination trial of human lymphoblastoid interferon and bestrabucil (KM2210) for adult T-cell leukemia–lymphoma. Cancer. 68(4). 695–698. 17 indexed citations
18.
Yamada, Kazumasa, Shigeru Shirakawa, Ryuzo Ohno, et al.. (1987). A phase II study of (2″ R)-4′ -0-tetrahydropyranyladriamycin (THP) in hematological malignancies. Investigational New Drugs. 5(3). 299–305. 2 indexed citations
19.
20.
Ohno, Ryuzo, Masami Hirano, Tadashi Kamiya, et al.. (1975). Daunorubicin, cytosine arabinoside, 6‐mercaptopurine riboside, and prednisolone (DCMP) combination chemotherapy for acute myelogenous leukemia in adults. Cancer. 36(6). 1945–1949. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hans Hartung Breakdown of academic impact, for papers by Thaddeus J. Unger Breakdown of academic impact, for papers by Jack C. Sipe Breakdown of academic impact, for papers by Gilles Edan Breakdown of academic impact, for papers by Sara Rollinson Breakdown of academic impact, for papers by Jacek Losy Breakdown of academic impact, for papers by S Nakazawa Breakdown of academic impact, for papers by Bonaventura Casanova Breakdown of academic impact, for papers by Anne Waschbisch Breakdown of academic impact, for papers by Carlo Avolio
Rankless by CCL
2026